{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:30:38Z","timestamp":1760956238924,"version":"3.33.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1136\/ard.60.90003.iii58","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T09:26:16Z","timestamp":1729502776000},"page":"iii58-iii61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S3","title":["New treatment options in ankylosing spondylitis: a role for anti-TNF\u03b1 therapy"],"prefix":"10.1016","volume":"60","author":[{"given":"J","family":"Sieper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.60.90003.iii58_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","article-title":"Prevalence of spondylarthropathies in HLA B27-positive and -negative blood donors","volume":"41","author":"Braun","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/rheumatology\/38.9.831","article-title":"Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy","volume":"38","author":"Brandt","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.60.90003.iii58_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.44.6.359","article-title":"Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway","volume":"44","author":"Gran","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.90003.iii58_bib4","first-page":"2622","article-title":"Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Societe de Rhumatologie de l'Ouest","volume":"26","author":"Saraux","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib5","first-page":"613","article-title":"Disability and handicap in rheumatoid arthritis and ankylosing spondylitis\u2014results from the German rheumatological database. German Collaborative Arthritis Centers","volume":"27","author":"Zink","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.60.4.353","article-title":"Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients","volume":"60","author":"Boonen","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.90003.iii58_bib7","first-page":"85","article-title":"Criteria of the classification of spondylarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1136\/ard.60.90003.iii58_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/38.3.235","article-title":"Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial","volume":"38","author":"Dougados","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.60.90003.iii58_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K","article-title":"Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug","volume":"44","author":"Dougados","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780380507","article-title":"Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study","volume":"38","author":"Dougados","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib11","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","article-title":"Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study","volume":"42","author":"Clegg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.1780310905","article-title":"Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial","volume":"31","author":"Nissila","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","article-title":"Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis","volume":"14","author":"Benitez-Del-Castillo","year":"2000","journal-title":"Eye"},{"key":"10.1136\/ard.60.90003.iii58_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2169\/internalmedicine.32.53","article-title":"Ankylosing spondylitis successfully treated with methotrexate","volume":"32","author":"Yamane","year":"1993","journal-title":"Intern Med"},{"key":"10.1136\/ard.60.90003.iii58_bib15","first-page":"1104","article-title":"Methotrexate in severe ankylosing spondylitis: an open study","volume":"22","author":"Creemers","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s100670050027","article-title":"Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study","volume":"19","author":"Biasi","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/030097400750002021","article-title":"Methotrexate in the treatment of ankylosing spondylitis","volume":"29","author":"Sampaio-Barros","year":"2000","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib18","first-page":"714","article-title":"An open study of pamidronate in the treatment of refractory ankylosing spondylitis","volume":"25","author":"Maksymowych","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib19","first-page":"144","article-title":"Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy","volume":"28","author":"Maksymowych","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1529-0131(199904)42:3<580::AID-ANR27>3.0.CO;2-D","article-title":"Efficacy of thalidomide in the treatment of refractory ankylosing spondylitis","volume":"42","author":"Breban","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s003930170077","article-title":"Therapy of ankylosing spondylitis with radium chloride","volume":"60","author":"Braun","year":"2001","journal-title":"Z Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780370709","article-title":"Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients","volume":"37","author":"Braun","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0889-857X(05)70038-7","article-title":"Radiology and pathology of the spondyloarthropathies","volume":"24","author":"Braun","year":"1998","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard.60.90003.iii58_bib24","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#","article-title":"Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy","volume":"41","author":"McGonagle","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis","volume":"38","author":"Braun","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib26","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/1529-0131(200009)43:9<2011::AID-ANR12>3.0.CO;2-Y","article-title":"Histopathologic evidence that sacroiliitis in ankylosing spondylitis is not merely enthesitis","volume":"43","author":"Francois","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.59.2.135","article-title":"T cells and macrophages predominate in early and active sacroiliitis as detected by magnetic resonance imaging in spondyloarthropathies","volume":"59","author":"Bollow","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.90003.iii58_bib28","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.60.4.316","article-title":"Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis","volume":"60","author":"Laloux","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.60.90003.iii58_bib29","first-page":"287","article-title":"HLA B27-related arthritis and bowel inflammation: sulfasalazine in HLA B27-related arthritis","volume":"12","author":"Mielants","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00054725-199905000-00008","article-title":"Anti-tumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results and safety","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1136\/ard.60.90003.iii58_bib31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","article-title":"Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial","volume":"356","author":"Mease","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ard.60.90003.iii58_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75) \u2013FC fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.60.90003.iii58_bib33","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.60.90003.iii58_bib34","first-page":"24","article-title":"Successful treatment of psoriatic arthritis with infliximab in an MRI controlled study","volume":"27(suppl 59)","author":"Antoni","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib35","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E","article-title":"Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab","volume":"43","author":"Brandt","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib36","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis. The Bath AS disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.59.6.428","article-title":"Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study","volume":"59","author":"Van den Bosch","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"10.1136\/ard.60.90003.iii58_bib38","first-page":"S403","article-title":"Etanercept in the treatment of ankylosing spondylitis: a randomized, double-blind, placebo-controlled study [abstract]","volume":"43","author":"Gorman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib39","first-page":"2225","article-title":"Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group","volume":"24","author":"van der Heijde","year":"1997","journal-title":"J Rheumatol"},{"unstructured":"Anderson JJ, Baron G, van der Heijde D, Felson DT, Felson M. ASAS preliminary criteria for short term improvement in ankylosing spondylitis. Arthritis Rheum (in press).","key":"10.1136\/ard.60.90003.iii58_bib40"},{"key":"10.1136\/ard.60.90003.iii58_bib41","first-page":"997","article-title":"Radiologic scoring methods in ankylosing spondylitis: reliability and sensitivity to change over one year","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.60.90003.iii58_bib42","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/1529-0131(199812)41:12<2263::AID-ART23>3.0.CO;2-I","article-title":"The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment","volume":"41","author":"MacKay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.60.90003.iii58_bib43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/rheumatology\/35.4.373","article-title":"Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS)","volume":"35","author":"Averns","year":"1996","journal-title":"Br J Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724434973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724434973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.60.90003.iii58","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T05:26:25Z","timestamp":1737264385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724434973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":43,"alternative-id":["S0003496724434973"],"URL":"https:\/\/doi.org\/10.1136\/ard.60.90003.iii58","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New treatment options in ankylosing spondylitis: a role for anti-TNF\u03b1 therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.60.90003.iii58","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}